We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BMRI:IDXPT Bank Mandiri (Persero) Tbk Analysis

Data as of 2026-09-02 - not real-time

IDR 4,340.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

PT Bank Mandiri (Persero) Tbk is priced at IDR 4,340.00, and its moving averages give no clean directional read — the structure is neutral. It has lost 2.5% over the past 30 days. Relative strength is 61.3 — approaching overbought — and the MACD signal is bullish. Watch IDR 4,080.00 as support and IDR 4,390.00 as the nearer resistance level.
Multiples put this in undervalued territory: 6.5 times earnings against the sector's 16.7. Analyst price targets sit 22.1% above the current price. Revenue is contracting at 5.4% on a 43.4% profit margin. The 11.04% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 24.1%, a beta of -0.08 and a maximum drawdown of 31.0%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top Market Events

economy.okezone2monBank Mandiri BMRI Raup Laba Bersih Rp23,3 Triliun hingga Mei 2026JAKARTA - PT Bank Mandiri Persero...Microsoft and our third-party vendors use cookies to store and access information such as unique IDs and personal...Bank Mandiri BMRI mencatat laba Rp15,4 triliun pada kuartal I/2026, tumbuh 16,6% berkat pertumbuhan kredit dan DPK.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading below the 200-day average of 4585.02
  • MACD momentum is positive
  • Maximum drawdown of 31.0%

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 6.5 versus sector average of 16.7
  • Trading below the 200-day average of 4585.02
  • Analyst targets imply +22.1% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 6.5 versus sector average of 16.7
  • Analyst targets imply +22.1% versus the current price
  • Profit margin of 43.4% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth-5.40%
Profit Margin43.38%
P/E Ratio6.5
ROE22.38%
ROA2.62%
P/B Ratio1.4
Op. Cash FlowIDR-292997803540480
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI61.3
SupportIDR 4,080.00
ResistanceIDR 4,390.00
MA 20IDR 4,201.00
MA 50IDR 4,158.60
MA 200IDR 4,585.03
MACDBullish
VolumeStable
Fear & Greed Index92.23

Valuation

Target PriceIDR 5,297.08
Upside/Downside22.05%
GradeUndervalued
TypeValue
Dividend Yield11.04%

Risk Assessment

Beta-0.08
Volatility24.11%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.